United Therapeutics
(NASDAQ:UTHR)
$262.40
4.27[1.65%]
At close: May 3
$262.40
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Wed May 1st, before the market open
The most recent conference call was at 9:00 AM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

United Therapeutics Stock (NASDAQ:UTHR), Quotes and News Summary

United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.

Open$260.330
Close$262.400
Volume / Avg.779.523K / 500.598K
Day Range255.930 - 262.510
52 Wk Range204.440 - 261.540
Market Cap$11.642B
P/E Ratio12.221
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
14.55%
Days to Cover8.73

Recent News

Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.
Vandana Singh
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial performance.
Vandana Singh
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
3
1
Feb
1
Mar
2
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
UTHR
LEGN

FAQ

Q

How do I buy United Therapeutics (UTHR) stock?

A

You can purchase shares of United Therapeutics (NASDAQ: UTHR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are United Therapeutics's (UTHR) competitors?

A

Other companies in United Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for United Therapeutics (UTHR) stock?

A

The latest price target for United Therapeutics (NASDAQ: UTHR) was reported by Goldman Sachs on Friday, May 3, 2024. The analyst firm set a price target for 240.00 expecting UTHR to fall to within 12 months (a possible -8.54% downside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for United Therapeutics (UTHR)?

A

The stock price for United Therapeutics (NASDAQ: UTHR) is $262.4 last updated May 3, 2024 at 4:00 PM EDT.

Q

Does United Therapeutics (UTHR) pay a dividend?

A

There are no upcoming dividends for United Therapeutics.

Q

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

A

United Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Q

Is United Therapeutics (UTHR) going to split?

A

There is no upcoming split for United Therapeutics.

Q

What sector and industry does United Therapeutics (UTHR) operate in?

A

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch